Talaulikar, DiptiTridgell, DavidLeong, David C SCherian, MayaSunderland, KenDahlstrom, Jane2015-12-101442-6404http://hdl.handle.net/1885/64872Ocular lymphoid tumours represent a spectrum of lymphoproliferative disease and can be subdivided into benign or reactive lymphoid hyperplasia, indeterminate or atypical lymphoid proliferations and malignant lymphoma. Treatment options include a wait andKeywords: rituximab; adult; article; B lymphocyte; case report; clinical decision making; exophthalmos; female; flow cytometry; follow up; human; immunoglobulin heavy chain gene; immunophenotyping; lymphoid hyperplasia; nuclear magnetic resonance imaging; orbit dis B-lymphocyte; Haematopathology; Lymphoproliferative disorder; Orbital; Pathology of lymphoid lesionNovel therapeutic option for orbital atypical lymphoid hyperplasia201010.1111/j.1442-9071.2010.02378.x2016-02-24